Health Economics Research Centre (HERC), University of Oxford

18/07/2025

NEW PUBLICATION

Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial

Junwen Zhou, Claire Williams, Natalie Staplin, Parminder K. Judge, Kaitlin J. Mayne, Nikita Agrawal, Ryoki Arimoto, Jennifer B. Green, David Z.I. Cherney, Katherine R. Tuttle, Jose Leal, Philip Clarke, Jonathan R. Emberson, David Preiss, Christoph Wanner, Martin J. Landray, Colin Baigent, Richard Haynes, William G. Herrington, Borislava Mihaylova, on behalf of the EMPA-KIDNEY Collaborative Group

eClinicalMedicine 2025

In EMPA-KIDNEY, 2 years treatment with empagliflozin improved QALYs, and reduced use and cost of other healthcare, resulting in high likelihood of cost-effectiveness across a broad range of patients with CKD. The study's key limitation is its relatively short active treatment period and follow-up du...

14/07/2025

NEW PUBLICATION

Systematic review of health economic models for assessment and diagnosis of dementia

Joseph Kwon, Lisanne Schoutens, Mitchell Burden, Charlotte Colam, Sihao Zhao, Behrouz Nezafat Maldonado, Elizabeth Blundell, Anastasia Krywonos, Jingjing Jiang, Maria Karagiannidou, Christoph Jindra, Nemanja Vaci, Nia Roberts, Raphael Wittenberg, Martin Knapp, Amparo Yovanna Castro Sanchez, Emilse Roncancio-Diaz, Michele Potashman, Robin Thompson, Ron Handels, Jane Wolstenholme, Alastair M. Gray, Filipa Landeiro, the ROADMAP Group

Alzheimer’s Dement. 2025

INTRODUCTION Timely diagnosis of dementia is a public health priority to enable risk modification and treatment access. This study systematically identifies and critically appraises health economic ...

08/07/2025

NEW PUBLICATION

Accuracy of online surveys in predicting COVID-19 uptake and demand: A cohort study investigating vaccine sentiments and switching in 13 countries from 2020 to 2022

Zachary D.V. Abel, Laurence S.J. Roope, Mara Violato, Philip M. Clarke

Vaccine 2025

16/06/2025

HERC SHORT COURSES 2025

The Health Economics Research Centre (HERC), University of Oxford, is pleased to announce their programme of Online short courses for 2025 and that registration is open now for bookings.

This year we have simplified our discount structure in that if you register for more than one Online-only course you will receive a 20% reduction on the overall cost. Further discounts are available to prospective participants from Lower to Middle-Income countries – please refer to our course pages on the HERC website for further information.

1. Introduction to Health Economic Evaluation 23-24 September
An online course for health professionals and health researchers who want to understand the basics of health economics and its relevance to the health service. No previous knowledge of economics required.
https://www.herc.ox.ac.uk/herc-short-courses/introduction-to-health-economic-evaluation

2. Applied Methods of Cost-Effectiveness Analysis 24-28 November (online)
This course is for health economists and health professionals with some knowledge of health economics who wish to learn about the methodology of cost-effectiveness analysis as applied in health care.
https://www.oxforduniversitystores.co.uk/short-courses/herc-short-courses/short-courses/applied-methods-of-cost-effectiveness-analysis-course

3. Cost-Effectiveness Analysis In Stata Using Participant-Level Data 02-04 December (online)
Designed for health economists and health professionals with a background in health economics who want to learn how to conduct cost-effectiveness analysis using the statistical software for data science Stata. Aimed at those who have participated in our Applied Methods of Cost-Effectiveness Analysis course (or similar)
https://www.herc.ox.ac.uk/herc-short-courses/cost-effectiveness-analysis-in-stata-using-participant-level-data

4. Inequality in Health and Health Care: Theoretical and Empirical Considerations 05-07 November (online)
Covering theoretical concepts on inequity and inequality in health as well as its measurement. This course will also provide an overview of selected available (longitudinal) household survey data and cohort studies that combine socio-economic and demographic variables along with various health measures – these datasets provide good sources for empirical inequality in health research.
https://www.herc.ox.ac.uk/herc-short-courses/online-inequality-in-health-and-health-care-theoretical-and-empirical-considerations-1-5pm-uk-bst-15-17-november

Discounts are available upon booking more than one of our online courses.

If you have any further queries, please contact the HERC Administration Team at: herc@ndph.ox.ac.uk

We look forward to welcoming you in 2025.

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functiona...

03/06/2025

NEW PUBLICATION

The Value of Hope in Cancer Care: Risk Preference and Heterogeneity in Cancer Patients and the General Public

Jihyung Hong, Eun-Young Bae, Shuye Yu

Value in Health 2025

19/05/2025

UPCOMING HERC SEMINAR

Core Outcome Set for Inflammatory Bowel Diseases

Dr Lisolette Fierens

Tues, 20 May, 11.00 - 12.00 UK BST, in person and online

Free event, requires registration

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functiona...

16/05/2025

HERC NEWS

Tutors and students enjoying HERC's choice modelling course this week!

15/05/2025

NEW PUBLICATION

Roux-en-Y gastric bypass, adjustable gastric banding, or sleeve gastrectomy for severe obesity (By-Band-Sleeve): a multicentre, open label, three-group, randomised controlled trial

The By-Band-Sleeve Collaborative Group (including Koen Pouwels, Rositsa Koleva-Kolarova, Sarah Wordsworth)

The Lancet Diabetes & Endocrinology, 2025



https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00025-7/fulltext

13/05/2025

HERC SHORT COURSES 2025

The Health Economics Research Centre (HERC), University of Oxford, is pleased to announce their programme of Online and In-person short courses for 2025 and that registration is open now for bookings.

This year we have simplified our discount structure in that if you register for more than one Online-only course or book for both In-person courses you will receive a 20% reduction on the overall cost. Further discounts are available to prospective participants from Lower to Middle-Income countries – please refer to our course pages on the HERC website for further information.

1. Introduction to Health Economic Evaluation 23-24 September
An online course for health professionals and health researchers who want to understand the basics of health economics and its relevance to the health service. No previous knowledge of economics required.
https://www.herc.ox.ac.uk/herc-short-courses/introduction-to-health-economic-evaluation

2. *Applied Methods of Cost-Effectiveness Analysis 02-04 June (in-person) Limited places available | 24-28 November (online)
This course is for health economists and health professionals with some knowledge of health economics who wish to learn about the methodology of cost-effectiveness analysis as applied in health care.
https://www.oxforduniversitystores.co.uk/short-courses/herc-short-courses/short-courses/applied-methods-of-cost-effectiveness-analysis-course

3. *Cost-Effectiveness Analysis In Stata Using Participant-Level Data 05-06 June (in-person) Limited places available | 02-04 December (online)
Designed for health economists and health professionals with a background in health economics who want to learn how to conduct cost-effectiveness analysis using the statistical software for data science Stata. Aimed at those who have participated in our Applied Methods of Cost-Effectiveness Analysis course (or similar)
https://www.herc.ox.ac.uk/herc-short-courses/cost-effectiveness-analysis-in-stata-using-participant-level-data

4. Inequality in Health and Health Care: Theoretical and Empirical Considerations 05-07 November (online)
Covering theoretical concepts on inequity and inequality in health as well as its measurement. This course will also provide an overview of selected available (longitudinal) household survey data and cohort studies that combine socio-economic and demographic variables along with various health measures – these datasets provide good sources for empirical inequality in health research.
https://www.herc.ox.ac.uk/herc-short-courses/online-inequality-in-health-and-health-care-theoretical-and-empirical-considerations-1-5pm-uk-bst-15-17-november

Discounts are available upon booking more than one of our online-only courses, or when booking the * asterisked in-person courses (Applied Methods of Cost-effectiveness Analysis and Cost-Effectiveness Analysis In Stata Using Participant-Level Data) together, detailed above.

If you have any further queries, please contact the HERC Administration Team at: herc@ndph.ox.ac.uk

We look forward to welcoming you in 2025.

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functiona...

10/04/2025

NEW PUBLICATION

Diagnosing Burkitt Lymphoma in Sub-Saharan Africa by Sequencing of Circulating Tumor DNA: A Comparative Microcosting Study

Liz Morrell, Malale Tungu, Caroline Achola, Ismail Legason, Erick Magorosa, Priscus Mapendo, Leah Mnango, Alex Mremi, Heavenlight Christopher, Emmanuel Josephat, Adam Burns, Helene Dreau, Mihaela Leonte, Lulu Chirande, Salama Mahawi, Elifuraha Mkwizu, Hadija Mwamtemi, Godlove Sandi, Claire El Mouden, Anna Schuh, George Ruhago, Sarah Wordsworth, on behalf of the AI-REAL Consortium

Value in Health Regional Issues 2025

Highlights

• Delayed or imprecise diagnosis contributes to the high burden of childhood lymphomas in sub-Saharan Africa. Diagnosis via sequencing of circulating tumor DNA (liquid biopsy) potentially offers rapid and specific diagnosis and avoids the need for invasive tissue biopsy.

• Microcosting found that liquid biopsy costs $525 more per patient than histopathology. These costs reduced with increased scale and strengthened local supply infrastructure.

• Liquid biopsy may nonetheless be cost effective in childhood cancers because many life years could be saved.

04/04/2025

NEW PUBLICATION

Reducing inequalities through greater diversity in clinical trials – As important for medical devices as for drugs and therapeutics

Laurence S.J. Roope, Jessica Walsh, Maddie Welland, Gabrielle Samuel, Heidi Johansen-Berg, Anna C. Nobre, Stuart Clare, Helen Higham, Jon Campbell, Tim Denison , Karla L. Miller, Seena Fazel, Matthew L. Costa, Andrew Farmer, Marian Knight, Rachel Taylor, Lorna R. Henderson, Angeli Vaid, John Geddes, Vasiliki Kiparoglou, Helen McShane, Philip M. Clarke

Contemporary Clinical Trials Communications 2025

Randomised controlled trials (RCTs) are the gold standard in medical research, yet they often lack diverse participants. This perspective highlights the potential consequences of unrepresentative study samples and emphasises the need for better evidence on improving trial diversity. We argue that Studies Within a Trial (SWATs) offer an ideal approach to generating this evidence.

31/03/2025

UPCOMING HERC SEMINAR

Financial Consequences of Undiagnosed Memory Disorders & Algorithms for Early Detection

Prof. Carole Roan Gresenz

Tues, 1 April, 13:30 hours UK BST, on-site and online via Zoom

Free event, requires registration
https://app.onlinesurveys.jisc.ac.uk/s/oxford/herc-webinar-carole-roan-gresenz-financial-consequences-of-undi

Abstract: We examine the effect of undiagnosed memory disorders on credit outcomes using individually matched nationally representative U.S. credit reporting and Medicare data. We find effects of early stage disease, years before diagnosis, on credit card and mortgage payment delinquency, credit utilization, and credit scores. Effects are pervasive, affecting seniors in single and coupled households, racial/ethnic minorities and non-minorities, and those in areas with higher/lower education levels. Early stage effects are greater among singles and Black individuals. Our findings highlight the importance of tools to facilitate earlier diagnosis, and we describe ongoing work designed to determine the feasibility of using credit data to facilitate early detection of memory disorders.

Bio: Carole Roan Gresenz is a Professor in the McCourt School of Public Policy at Georgetown University and holds the Bette Jacobs Endowed Professorship in the Department of Health Management and Policy. She worked at the RAND Corporation for two decades before joining Georgetown and has held senior leadership roles at both organizations. She holds a Ph.D. and M.A. in economics from Brown University and a B.A. in economics from Loyola University Maryland.